| Jay Jonathan Richards, DO | |
|
150 Ne Kenneth Ford Dr, Roseburg, OR 97470-1042 | |
| (541) 672-9596 | |
| (541) 672-7146 |
| Full Name | Jay Jonathan Richards |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 150 Ne Kenneth Ford Dr, Roseburg, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225214489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | DO164085 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center | Roseburg, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umpqua Community Health Center Inc | 0345233078 | 21 |
News Archive
Senesco Technologies, Inc., announced today that the characteristics and activity of SNS01 have been released on-line in Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
› Verified 8 days ago
| Entity Name | Umpqua Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396751772 PECOS PAC ID: 0345233078 Enrollment ID: O20040511000463 |
News Archive
Senesco Technologies, Inc., announced today that the characteristics and activity of SNS01 have been released on-line in Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Jonathan Richards, DO 150 Ne Kenneth Ford Dr, Roseburg, OR 97470-1042 Ph: (541) 672-9596 | Jay Jonathan Richards, DO 150 Ne Kenneth Ford Dr, Roseburg, OR 97470-1042 Ph: (541) 672-9596 |
News Archive
Senesco Technologies, Inc., announced today that the characteristics and activity of SNS01 have been released on-line in Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
› Verified 8 days ago
Dr. John Travis Melling, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Ne Kenneth Ford Dr, Roseburg, OR 97470 Phone: 541-672-9596 Fax: 541-646-3519 | |
Candace Marie Hatton, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 272 Nw Medical Loop Ste B, Roseburg, OR 97471 Phone: 541-537-8007 | |
Dr. Brandon W Bonds, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2570 Nw Edenbower Blvd Ste 100, Roseburg, OR 97471 Phone: 541-677-7200 Fax: 541-229-3309 | |
Dr. Marie Hebert, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 340 Nw Medical Loop, Roseburg, OR 97471 Phone: 541-464-5907 Fax: 541-464-8481 | |
Dr. Gerald Andrew Jaworski, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2282 Nw Troost St, Ste. 101, Roseburg, OR 97471 Phone: 541-673-0609 Fax: 541-440-9387 | |
Dr. Derwood E Basham, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2371 Ne Stephens St, Suite 200, Roseburg, OR 97470 Phone: 541-672-8533 Fax: 541-672-4993 | |
Ms. Patricia A Hedges, RD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2371 Ne Stephens St Ste 200, Roseburg, OR 97470 Phone: 541-672-8533 Fax: 541-677-5574 |